Skip to content

Hybrid imaging using PET/CT and PET/MRI in nuclear medicine diagnostics: technical outcome, clinical results, complications and economic implications - a prospective registry study

Hybrid imaging using PET/CT and PET/MRI in nuclear medicine diagnostics: technical outcome, clinical results, complications and economic implications - a prospective registry study - REGPET

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00036119
Enrollment
1000
Registered
2025-03-13
Start date
2025-01-31
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with different diagnosis (oncological and non-oncological) who receive a PET/CT or PET/MRI in clinical routine

Interventions

Group 1: Patients who receive a PET/CT or PET/MRI in clinical routine

Sponsors

Universitätsklinikum Mannheim (UMM)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. indication for PET/CT according to the medical practice/clinical indication at the DKFZ or the UMM 2. indication for PET/MRI according to medical practice/clinical indication at the DKFZ or UMM indication at the DKFZ or the UMM 3. targeted disease-specific question for PET/CT or PET/MRI 4. age 18 years or older 5. ongoing or beginning targeted therapy 6. sufficient communication skills in the German language 7. patient must be able to recognize the nature, significance and scope of this to recognize the nature, significance and scope of this register and to align their will accordingly 8. availability by telephone

Exclusion criteria

Exclusion criteria: 1. age < 18 years 2. lack of declaration of consent 3. pregnancy

Design outcomes

Primary

MeasureTime frame
Diagnostic performance of PET/CT or PET/MRI

Secondary

MeasureTime frame
Diagnostic performance of other imaging modalities (MRI, CT)

Countries

Germany

Contacts

Public ContactFreba Grawe

Hector Krebsinstitut

freba.grawe@dkfz-heidelberg.de+49 6221 42 2263

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026